Suppr超能文献

壳聚糖涂层可增强硫酸钙基抗生素疗法在慢性骨髓炎治疗中的疗效。

Chitosan coating to enhance the therapeutic efficacy of calcium sulfate-based antibiotic therapy in the treatment of chronic osteomyelitis.

作者信息

Beenken Karen E, Smith James K, Skinner Robert A, Mclaren Sandra G, Bellamy William, Gruenwald M Johannes, Spencer Horace J, Jennings Jessica A, Haggard Warren O, Smeltzer Mark S

机构信息

Department of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.

Department of Biomedical Engineering, University of Memphis, Memphis, TN, USA.

出版信息

J Biomater Appl. 2014 Oct;29(4):514-23. doi: 10.1177/0885328214535452. Epub 2014 May 21.

Abstract

We demonstrate that coating calcium sulfate with deacetylated chitosan enhances the elution profile of daptomycin by prolonging the period during which high concentrations of antibiotic are released. Coatings reduced initial bolus release of daptomycin by a factor of 10 to approximately 1000 µg/ml, and levels remained above 100 µg/ml for up to 10 days. Chitosan-coated and uncoated calcium sulfate implants with and without 15% daptomycin were evaluated in an experimental model of staphylococcal osteomyelitis through bacteriology scores, radiology, histopathology, and Gram staining. Significant reduction in bacteriology scores was observed for implants containing daptomycin and coated with chitosan compared with all the other groups. We confirm that the use of chitosan-coated calcium sulfate beads for local antibiotic delivery can be correlated with an improved therapeutic outcome following surgical debridement in the treatment of chronic osteomyelitis.

摘要

我们证明,用脱乙酰壳聚糖包覆硫酸钙可通过延长高浓度抗生素释放的时间来增强达托霉素的洗脱曲线。包覆层将达托霉素的初始大剂量释放降低了10倍,降至约1000µg/ml,且其水平在长达10天的时间内保持在100µg/ml以上。通过细菌学评分、放射学、组织病理学和革兰氏染色,在葡萄球菌性骨髓炎的实验模型中评估了含15%达托霉素和不含15%达托霉素的壳聚糖包覆和未包覆的硫酸钙植入物。与所有其他组相比,观察到含达托霉素且用壳聚糖包覆的植入物的细菌学评分显著降低。我们证实,在慢性骨髓炎的治疗中,使用壳聚糖包覆的硫酸钙珠进行局部抗生素递送与手术清创后改善的治疗结果相关。

相似文献

2
Use of xylitol to enhance the therapeutic efficacy of polymethylmethacrylate-based antibiotic therapy in treatment of chronic osteomyelitis.
Antimicrob Agents Chemother. 2012 Nov;56(11):5839-44. doi: 10.1128/AAC.01127-12. Epub 2012 Sep 4.
4
Daptomycin: local application in implant-associated infection and complicated osteomyelitis.
ScientificWorldJournal. 2012;2012:578251. doi: 10.1100/2012/578251. Epub 2012 Jun 18.
6
Experimental osteomyelitis treatment with antibiotic-impregnated hydroxyapatite.
Clin Orthop Relat Res. 2002 Aug(401):239-47. doi: 10.1097/00003086-200208000-00027.
8
Efficacy of daptomycin combined with rifampicin for the treatment of experimental meticillin-resistant Staphylococcus aureus (MRSA) acute osteomyelitis.
Int J Antimicrob Agents. 2010 Dec;36(6):542-4. doi: 10.1016/j.ijantimicag.2010.07.008. Epub 2010 Sep 18.
10
Regional antibiotic delivery for the treatment of experimental prosthetic graft infections.
J Surg Res. 2009 Dec;157(2):223-6. doi: 10.1016/j.jss.2008.06.050. Epub 2008 Aug 14.

引用本文的文献

5
Design and Manufacture of Bone Cements Based on Calcium Sulfate Hemihydrate and Mg, Sr-Doped Bioactive Glass.
Biomedicines. 2023 Oct 18;11(10):2833. doi: 10.3390/biomedicines11102833.
7
Current research progress of local drug delivery systems based on biodegradable polymers in treating chronic osteomyelitis.
Front Bioeng Biotechnol. 2022 Nov 24;10:1042128. doi: 10.3389/fbioe.2022.1042128. eCollection 2022.
8
Chitosan-Based Biomaterial Scaffolds for the Repair of Infected Bone Defects.
Front Bioeng Biotechnol. 2022 May 4;10:899760. doi: 10.3389/fbioe.2022.899760. eCollection 2022.
10
Recent advances in the local antibiotics delivery systems for management of osteomyelitis.
Drug Deliv. 2021 Dec;28(1):2392-2414. doi: 10.1080/10717544.2021.1998246.

本文引用的文献

1
Composite chitosan and calcium sulfate scaffold for dual delivery of vancomycin and recombinant human bone morphogenetic protein-2.
J Mater Sci Mater Med. 2014 Jun;25(6):1449-59. doi: 10.1007/s10856-014-5167-7. Epub 2014 Feb 7.
2
Attachment, proliferation, and chondroinduction of mesenchymal stem cells on porous chitosan-calcium phosphate scaffolds.
Open Orthop J. 2013 Jul 30;7:275-81. doi: 10.2174/1874325001307010275. eCollection 2013.
3
Chitosan sponges for local synergistic infection therapy: a pilot study.
Clin Orthop Relat Res. 2013 Oct;471(10):3158-64. doi: 10.1007/s11999-013-2988-5. Epub 2013 Apr 20.
4
Biodegradable vs non-biodegradable antibiotic delivery devices in the treatment of osteomyelitis.
Expert Opin Drug Deliv. 2013 Mar;10(3):341-51. doi: 10.1517/17425247.2013.751371. Epub 2013 Jan 6.
6
Preliminary investigation of crosslinked chitosan sponges for tailorable drug delivery and infection control.
J Biomed Mater Res B Appl Biomater. 2013 Jan;101(1):110-23. doi: 10.1002/jbm.b.32822. Epub 2012 Sep 21.
7
Use of xylitol to enhance the therapeutic efficacy of polymethylmethacrylate-based antibiotic therapy in treatment of chronic osteomyelitis.
Antimicrob Agents Chemother. 2012 Nov;56(11):5839-44. doi: 10.1128/AAC.01127-12. Epub 2012 Sep 4.
8
The antimicrobial action of chitosan, low molar mass chitosan, and chitooligosaccharides on human colonic bacteria.
Folia Microbiol (Praha). 2012 Jul;57(4):341-5. doi: 10.1007/s12223-012-0138-1. Epub 2012 Apr 13.
9
Determination of efficacy of novel modified chitosan sponge dressing in a lethal arterial injury model in swine.
J Trauma Acute Care Surg. 2012 Apr;72(4):899-907. doi: 10.1097/TA.0b013e318248baa1.
10
Chitosan derivatives with antimicrobial, antitumour and antioxidant activities--a review.
Curr Pharm Des. 2011;17(32):3596-607. doi: 10.2174/138161211798194468.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验